Reflections on the Human Condition - Api-fellowships.org
Reflections on the Human Condition - Api-fellowships.org
Reflections on the Human Condition - Api-fellowships.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
202 SESSION III<br />
cook tasty food, communicate well, teach English to <strong>the</strong><br />
children of <strong>the</strong>ir wealthy employers for free, and learn<br />
Cant<strong>on</strong>ese almost immediately, is rewarded in many<br />
cases with being treated as a very low-class citizen—not<br />
to menti<strong>on</strong> a back-breaking, full six-day work-week and<br />
a single trip to see <strong>the</strong> family back home <strong>on</strong>ce every two<br />
years.”<br />
Escobar also has <strong>the</strong> appropriate last word:<br />
Notes<br />
“The Filipinos are a capable, well-educated, joyful<br />
people. Most who have settled abroad, [who have]<br />
escaped <strong>the</strong> misery of semi-feudal rule and been<br />
given <strong>the</strong> opportunity to prosper, have d<strong>on</strong>e so. But,<br />
of course, <strong>the</strong>y can’t all emigrate or become overseas<br />
workers. Ultimately, <strong>the</strong>y will need to find <strong>the</strong><br />
political means to rid <strong>the</strong>mselves of <strong>the</strong> oppressive<br />
medieval structures that make <strong>the</strong>ir lives <strong>on</strong> Earth<br />
<strong>the</strong> equivalent of purgatory.”<br />
1 Ha-Jo<strong>on</strong> Chang. 2001. Breaking <strong>the</strong> Mould: An<br />
Instituti<strong>on</strong>alist Political Ec<strong>on</strong>omy Alternative to <strong>the</strong><br />
Neoliberal Theory of <strong>the</strong> Market and <strong>the</strong> State. Social<br />
Policy & Development Program Paper No. 6. Geneva:<br />
UNRISD.<br />
2 Investing in Health, World Development Report, 1993.<br />
Washingt<strong>on</strong>, DC: World Bank.<br />
3 UE Reinhardt. 2001. “Can efficiency in health care be<br />
left to <strong>the</strong> market?”. In Journal of Health Politics, Policy<br />
and Law, 26 (5): 967-992.<br />
4 see for example, EL Hannan, M Racz, TJ Ryan et al. 1997.<br />
“Cor<strong>on</strong>ary angioplasty volume-outcome relati<strong>on</strong>ships<br />
for hospitals and cardiologists”. In Journal of American<br />
Medical Associati<strong>on</strong> 277: 892-898.<br />
5 Suleiman, Abu Bakar; W<strong>on</strong>g, Swee Lan; Mohan, A. Jai;<br />
et al. 1993. Utilisati<strong>on</strong> of Specialist Medical Manpower.<br />
Report of a collaborative study by <strong>the</strong> Ministry of<br />
Health and <strong>the</strong> Academy of Medicine, Malaysia, 1992-<br />
1993.<br />
6 quite apart from ec<strong>on</strong>omic barriers to existing<br />
treatments, Médecins Sans Fr<strong>on</strong>tières (MSF) has<br />
highlighted <strong>the</strong> persistent problems of neglected<br />
diseases: of <strong>the</strong> 1,393 new drugs approved between<br />
1975 and 1999, <strong>on</strong>ly 16 (or just over 1 percent) were<br />
specifically developed for tropical diseases (such as<br />
malaria, sleeping sickness, Chagas’ disease, kala azar)<br />
and tuberculosis, diseases that account for 11.4 percent<br />
Ref lecti<strong>on</strong>s <strong>on</strong> <strong>the</strong> <strong>Human</strong> C<strong>on</strong>diti<strong>on</strong>: Change, C<strong>on</strong>flict and Modernity<br />
The Work of <strong>the</strong> 2004/2005 API Fellows<br />
of <strong>the</strong> global disease burden. For 13 out of those 16<br />
drugs, two were modificati<strong>on</strong>s of existing medicines,<br />
two were produced for <strong>the</strong> US military, and five came<br />
from veterinary research. Only four were developed<br />
by commercial pharmaceutical companies specifically<br />
for tropical diseases in humans. These tropical diseases<br />
mainly affect poorer communities in countries of <strong>the</strong><br />
South, which do not c<strong>on</strong>stitute a valuable enough<br />
market to stimulate adequate R&D by <strong>the</strong> multinati<strong>on</strong>al<br />
pharmaceutical companies. ref: P Trouiller, P Olliaro,<br />
E Torreele, J Orbinski, R Laing, N Ford. 2002. Drug<br />
Development for Neglected Diseases: A Deficient<br />
Market and a Public Health Policy Failure. Lancet 359:<br />
2188-2194 (22 June 2002); R Cohen. 2002. Neglected<br />
Diseases and <strong>the</strong> Health Burden in Poor Countries.<br />
Multinati<strong>on</strong>al M<strong>on</strong>itor, June 2002; Michael Kremer &<br />
Rachel Glannerster, “Creating a Market for Vaccines”<br />
in New York Times, 1 June 2001.<br />
7 Woolhandler, S and D. Himmelstein. 1999. “When<br />
M<strong>on</strong>ey is <strong>the</strong> Missi<strong>on</strong>: The High Costs of Investor-<br />
Owned Care”. In New England Journal of Medicine<br />
341: 444-446; P Devereaux, P Choi, C Lacchett, et al.<br />
2002. “A systematic review and meta-analysis of studies<br />
comparing mortality rates of private for-profit and<br />
private not-for-profit hospitals”. In Canadian Medical<br />
Associati<strong>on</strong> Journal 166: 1399-1406; Woolhandler, S.;<br />
Campbell, T. and Himmelstein, D. 2003. “Costs of<br />
Health Care Administrati<strong>on</strong> in <strong>the</strong> United States and<br />
Canada”. In New England Journal of Medicine 349:768-<br />
775; D<strong>on</strong>ald Light (ed.). 2001. “Comparative Studies<br />
of Competiti<strong>on</strong> Policy”. In Social Science and Medicine<br />
52(8), special issue, April 2001; Heller, PS. 1982. “A<br />
Model of <strong>the</strong> Demand for Medical and Health Services<br />
in Peninsular Malaysia”. In Social Science & Medicine<br />
16: 267-284.<br />
8 see for example William Greider. 1997. One World,<br />
Ready or Not: The Manic Logic of Global Capitalism.<br />
New York: Sim<strong>on</strong> & Schuster; and a critical early<br />
review by Lester Thurow, The Atlantic M<strong>on</strong>thly, March<br />
1997, disputing <strong>the</strong> claims of overcapacity.<br />
9 in <strong>the</strong> terminology of <strong>the</strong> neo-Keynesian French<br />
Regulati<strong>on</strong> School, this would be an instance of<br />
“regulati<strong>on</strong> failure” and crisis of <strong>the</strong> existing regime<br />
of accumulati<strong>on</strong>: “<strong>the</strong>re are l<strong>on</strong>g periods of time when<br />
things work, when <strong>the</strong> c<strong>on</strong>figurati<strong>on</strong> of social relati<strong>on</strong>s<br />
that defines capitalism, for instance, reproduces itself in a<br />
stabilized way. We call such a c<strong>on</strong>tinuing system a regime<br />
of accumulati<strong>on</strong>. This refers, of course, to ec<strong>on</strong>omics but this<br />
can be extended to politics, diplomacy, and so <strong>on</strong>… we have<br />
to think [also] about <strong>the</strong> ways this regime of accumulati<strong>on</strong><br />
is achieved… individual expectati<strong>on</strong>s and behavior must